Brought to you by:
Local matters: Three community service honorees in profile
The Society for Vascular Surgery (SVS) has honored three members in community practice for their leadership of patients and their local communities, as well as exemplary professional practice and leadership. Recipients of the Excellence in Community Service Award, in only…
Through the looking glass: Addressing bias in surgery
The #Medbikini campaign spread like wildfire following the publication of the journal article in question. Reading the manuscript seemed like we crossed the threshold of Lewis Carroll’s looking glass into a bizarre, flipped universe of odd definitions of professionalism, unethical…
Cigarette tax rises lead to drop in active smoking in claudication patients, study finds
Increases in cigarette taxes appear to be an effective strategy to cut active smoking among patients who are undergoing interventions for intermittent claudication, the New England Society for Vascular Surgery (NESVS) virtual annual meeting (Sept. 11–12) heard. That was the…
CX Aortic Vienna reveals preoccupation with radiation reduction, showcases latest CT tech
Polling at CX Aortic Vienna points to a high level of vigilance over radiation exposure during endovascular aneurysm repair (EVAR). This was among the messages to emerge from a discussion on the optimal use of aortic imaging for diagnostic purposes…
AVF schedules education series for trainees, early-career practitioners
The American Venous Forum (AVF) is to stage a four-part series of educational sessions running the gamut of venous disorders aimed at residents, fellows and early-career practitioners in vascular surgery, interventional radiology and a host of other specialties. The live,…
‘No signal of increased risk of long-term mortality’ with paclitaxel-coated Luminor DCB, EffPac trial finds
An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two years of drug-coated balloon (DCB) angioplasty using a Luminor-35 device (iVascular). This was the conclusion presented by…
New data support televascular visits to help address rural vascular surgery shortage
Researchers from the University of Minnesota unveiled new data supporting televascular consultations as a viable solution to the shortage of vascular surgeons in rural parts of the United States during the Midwestern Vascular Surgical Society (MVSS) annual meeting held virtually…
Leadership: Spotlight on Amy Reed, MD
This interview continues our series of conversations with national vascular surgery leaders based on topics from the Kouznes and Pozner book “The Truth About Leadership.” This column highlights evidence-based behaviors on how to make a change stick. Amy Reed, MD,…
Coding workshop: Keep the money you deserve
Coding for aneurysm repair, for catheterization, for lower-extremity amputation. Information on modifiers, not to mention reimbursement appeals. And don’t forget new guidelines for Evaluation and Management (E/M) codes that take effect Jan. 1 next year. Attendees of this year’s virtual…
IN.PACT Admiral DCB shows ‘significant advantage’ over uncoated devices in fempop artery treatment analysis
The IN.PACT Admiral drug-coated balloon (DCB) demonstrated a significant advantage in overall survival, amputation-free survival and target-lesion revascularization after femoropopliteal artery treatment through four-year follow-up when compared to uncoated balloons, a single-institution, retrospective review that tackled a head-to-head comparison between…